Site-specific DNA-antibody conjugates for specific and sensitive immuno-PCR

Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment

(2011) C. Xiao et al.   ANNALS OF ONCOLOGY

Selective Formation of Covalent Protein Heterodimers with an Unnatural Amino Acid

(2011) Benjamin M. Hutchins et al.   CHEMISTRY & BIOLOGY

Site-Specific Coupling and Sterically Controlled Formation of Multimeric Antibody Fab Fragments with Unnatural Amino Acids

(2011) Benjamin M. Hutchins et al.   JOURNAL OF MOLECULAR BIOLOGY

Antibody validation

(2010) Jennifer Bordeaux et al.   BIOTECHNIQUES

Analytic Variability in Immunohistochemistry Biomarker Studies

(2010) V. K. Anagnostou et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

(2010) S. L. Stott et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ultrasensitive Detection of Low-Abundance Surface-Marker Protein Using Isothermal Rolling Circle Amplification in a Microfluidic Nanoliter Platform

(2010) Tania Konry et al.   Small

Prognostic and Predictive Value of HER2 Extracellular Domain in Metastatic Breast Cancer Treated With Lapatinib and Paclitaxel in a Randomized Phase III Study

(2009) Richard S. Finn et al.   JOURNAL OF CLINICAL ONCOLOGY

Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy

(2009) C. S. Thaxton et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Programming biomolecular self-assembly pathways

(2008) Peng Yin et al.   NATURE